Last reviewed · How we verify

NCT04215094

Early Diagnosis of Intracranial Infection After Craniotomy

Status unknown Last updated 23 October 2020
What this trial tests

trial testing postoperative fever, serum procalcitonin, C-reactive protein and white blood cell coun in Intracranial; Infection, Psychosis, Acute or Subacute in 500 participants. Status unknown.

Timeline
12 January 2020
Primary endpoint
12 July 2021
1 August 2021

Quick facts

Lead sponsorPan Jun
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment500
Start date12 January 2020
Primary completion12 July 2021
Estimated completion1 August 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Pan Jun

Who can join

Adults 18 to 68, any sex, with Intracranial; Infection, Psychosis, Acute or Subacute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intracranial infection are serious complications postoperatively in neurosurgical patients. Early identification of these complications is essential to minimize the mortality and moribidy. The aim of this study is observe the postoperative dynamic changes of body temperature (BT), procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) count, and evaluate whether the use of two or more of these markers may improve the diagnostic accuracy of intracranial infection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04215094.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing